31.08.2013 Views

Experimental infection and protection against ... - TI Pharma

Experimental infection and protection against ... - TI Pharma

Experimental infection and protection against ... - TI Pharma

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

22 Chapter 1<br />

References<br />

1. World Malaria Report, 2011. (http://www.who.int/malaria)<br />

2. Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg 2001;<br />

64:85-96.<br />

3. Desai M, ter Kuile FO, Nosten F et al. Epidemiology <strong>and</strong> burden of malaria in<br />

pregnancy. Lancet Infect Dis 2007; 7:93-104.<br />

4. Fauci AS, Braunwald E, Kasper DL et al. Harrison's Internal Medicine. 17 ed.<br />

2008.<br />

5. Millennium Development Goals, 2012. (www.un.org/millenniumgoals)<br />

6. WHO guidelines for the treatment of malaria, 2011.<br />

(http://www.who.int/malaria/publications/atoz/9789241547925/en/index.htm<br />

l)<br />

7. Mendis K, Rietveld A, Warsame M, Bosman A, Greenwood B, Wernsdorfer WH.<br />

From malaria control to eradication: The WHO perspective. Trop Med Int Health<br />

2009; 14:802-809.<br />

8. World Malaria Report, 2011. (http://www.who.int/malaria)<br />

9. Alonso PL, Brown G, Arevalo-Herrera M et al. A research agenda to underpin<br />

malaria eradication. PLoS Med 2011; 8:e1000406.<br />

10. Malaria Vaccine Technology Roadmap, 2006.<br />

(http://www.malariavaccine.org/files/Malaria_Vaccine_TRM_Final_000.pdf)<br />

11. Crompton PD, Pierce SK, Miller LH. Advances <strong>and</strong> challenges in malaria vaccine<br />

development. J Clin Invest 2010; 120:4168-4178.<br />

12. Sauerwein RW, Roestenberg M, Moorthy VS. <strong>Experimental</strong> human challenge<br />

<strong>infection</strong>s can accelerate clinical malaria vaccine development. Nat Rev<br />

Immunol 2011; 11:57-64.<br />

13. Greenwood BM, Targett GA. Malaria vaccines <strong>and</strong> the new malaria agenda. Clin<br />

Microbiol Infect 2011; 17:1600-1607.<br />

14. Wang R, Doolan DL, Le TP et al. Induction of antigen-specific cytotoxic T<br />

lymphocytes in humans by a malaria DNA vaccine. Science 1998; 282:476-480.<br />

15. Hill AV, Reyes-S<strong>and</strong>oval A, O'Hara G et al. Prime-boost vectored malaria<br />

vaccines: progress <strong>and</strong> prospects. Hum Vaccin 2010; 6:78-83.<br />

16. WHO Malaria Vaccine Rainbow Table, 2011.<br />

(http://www.who.int/vaccine_research/links/Rainbow/en/index.html)<br />

17. Mazier D, Goma J, Pied S et al. Hepatic phase of malaria: a crucial role as "gobetween"<br />

with other stages. Bull World Health Organ 1990; 68 Suppl:126-131.<br />

18. Krzych U, Lyon JA, Jareed T et al. T lymphocytes from volunteers immunized<br />

with irradiated Plasmodium falciparum sporozoites recognize liver <strong>and</strong> blood<br />

stage malaria antigens. J Immunol 1995; 155:4072-4077.<br />

19. Belnoue E, Voza T, Costa FT et al. Vaccination with live Plasmodium yoelii blood<br />

stage parasites under chloroquine cover induces cross-stage immunity <strong>against</strong><br />

malaria liver stage. J Immunol 2008; 181:8552-8558.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!